Insider: Bassler Bonnie L Director - REGENERON PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 1,703 | 0 | 1,703 |
| Value | $1,297,430.55 | $0.00 | $1,297,430.55 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/07/2026 | DDS | 1,500 | Direct | COM | $800.00 | $1,200,000.00 | 1,703 |
| 11/20/2025 | DDS | 760 | Direct | COM | $750.00 | $570,000.00 | 1,548 |
| 08/15/2024 | DDS | 756 | Direct | COM | $1,170.00 | $884,520.00 | 1,382 |
| 08/02/2024 | DDS | 756 | Direct | COM | $1,115.00 | $842,940.00 | 1,382 |
| 06/24/2024 | DDS | 756 | Direct | COM | $1,062.00 | $802,872.00 | 1,382 |
| 06/05/2024 | DDS | 827 | Direct | COM | $1,011.00 | $836,097.00 | 1,382 |
| 02/26/2024 | DDS | 854 | Direct | COM | $979.25 | $836,279.50 | 1,382 |
| 01/30/2024 | DDS | 827 | Direct | COM | $959.00 | $793,093.00 | 1,382 |
| 12/13/2023 | DDS | 610 | Direct | COM | $870.00 | $530,700.00 | 1,247 |
| 08/21/2023 | DDS | 853 | Direct | COM | $829.00 | $707,137.00 | 1,247 |
| 08/10/2023 | DDS | 853 | Direct | COM | $789.00 | $673,017.00 | 1,247 |
| 03/24/2023 | DDS | 1,240 | Direct | COM | $818.00 | $1,014,320.00 | 1,247 |
| 02/03/2023 | DDS | 1,021 | Direct | COM | $779.00 | $795,359.00 | 1,247 |
| 12/08/2022 | DDS | 218 | Direct | COM | $779.00 | $169,822.00 | 1,082 |
| 09/09/2022 | DDS | 609 | Direct | COM | $741.00 | $451,269.00 | 1,082 |
| 09/08/2022 | DDS | 1,279 | Direct | COM | $705.00 | $901,695.00 | 1,082 |
| 09/08/2022 | DDS | 1,279 | Direct | COM | $686.99 | $878,660.21 | 1,082 |
| 04/07/2022 | DDS | 1,240 | Direct | COM | $725.00 | $899,000.00 | 1,082 |
| 03/30/2022 | DDS | 1,240 | Direct | COM | $700.00 | $868,000.00 | 1,082 |
| 08/16/2021 | DDS | 1,219 | Direct | COM | $630.00 | $767,970.00 | 891 |
| 08/05/2021 | DDS | 2,559 | Direct | COM | $600.00 | $1,535,400.00 | 891 |
| 07/01/2021 | DDS | 2,558 | Direct | COM | $575.00 | $1,470,850.00 | 891 |
| 06/19/2020 | DDS | 11 | Direct | COM | $631.37 | $6,945.07 | 643 |
| 06/19/2020 | DDS | 2,548 | Direct | COM | $630.01 | $1,605,265.48 | 654 |
| 06/05/2020 | DDS | 2,559 | Direct | COM | $600.00 | $1,535,400.00 | 643 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research